Our aim was to characterize the association of lipoprotein-associated phospholipase A 2 (Lp-PLA 2 ) with coronary and aortic atherosclerosis in a large population-based study.
is an enzyme that circulates largely bound to lowdensity lipoproteins (1 ) . Although higher Lp-PLA 2 levels have been associated with an increased incidence of cardiovascular events in several (but not all (2 )) studies, as summarized in a recent metaanalysis (1 ) , it remains unclear whether Lp-PLA 2 is a marker of atherosclerosis development and progression (i.e., "burden"), the biological activity and instability of existing plaque (3 ), or both.
We measured circulating Lp-PLA 2 mass and activity in a large, multiethnic, population-based cohort from Dallas, Texas, to determine: a) the association of Lp-PLA 2 with coronary artery calcification (CAC) as measured by electron beam computed tomography (EBCT); and b) the association of Lp-PLA 2 measures with abdominal aortic atherosclerosis and wall thickness as measured by magnetic resonance imaging (MRI).
Materials and Methods

STUDY POPULATION
The Dallas Heart Study is a population-based, probability sample of 6101 subjects in Dallas County that was designed to study early stages of cardiovascular disease, as described in detail (4 ) . Briefly, a stratified random sample of Dallas County residents age 18 -65 years was obtained from a pool of 841 943 eligible subjects using the US Postal Service Delivery Sequence File, with deliberate oversampling of African Americans. An initial visit for 6101 participants included a detailed in-home interview for demographic and health-related data, as well as measurements of weight, heart rate, and blood pressure (5 sequential measures). All subjects between the ages of 30 and 65 who completed the initial visit were invited to participate in a second in-home visit to collect fasting venous blood and urine samples and, if they completed the second visit, a third detailed clinic visit that included abdominal aortic MRI and cardiac EBCT to assess CAC. A total of 3399 subjects completed the second visit, and 2171 subjects completed the third visit. In the present study, we included all 2171 subjects who had complete data from Lp-PLA 2 measurements, cardiac EBCT, and aortic MRI. The study was approved by our Institutional Review Board, and every patient gave written informed consent.
LP-PLA 2 ASSAYS
Blood samples were obtained in EDTA tubes and were stored for Յ4 h at 4°C before processing, with plasma aliquots stored at Ϫ80°C. Lp-PLA 2 activity was measured with a colorimetric activity method provided by GlaxoSmithKline (5 ). The mean duplicate CV was 2.94% for the low controls and 3.85% for the high controls. The mean duplicate CV for samples was 3.87% (5 ) .
Lp-PLA 2 mass was measured by diaDexus, Inc., using a dual monoclonal antibody immunoassay standardized to recombinant Lp-PLA 2 , as described (5 ) . The mean duplicate CV was 2.89% for the low controls and 3.23% for the high controls. Because of limited plasma quantities, Lp-PLA 2 mass measurements were run singly (5 ) . There was a strong correlation between Lp-PLA 2 mass and activity (Spearman ϭ 0.69, P Ͻ 0.001) (5 ) . All analyses were performed using a Molecular Devices microplate reader, and the day-to-day CV for LP-PLA 2 activity and mass ranged from 2.9% to 3.9% and from 2.1% to 4.2%, respectively.
COMPUTED TOMOGRAPHY
We performed EBCT using an Imatron 150 XP, 30 cm FOV, 512 matrix with sharp kernel reconstruction, with measurements obtained at 80% of the RR interval. Calcium scoring followed the protocol of the Multi Ethnic Study of Atherosclerosis (MESA) (6 ) . Detection of calcium was based on a focus of calcium with Ն3 contiguous pixels and a CT threshold of 130 Hounsfield units (HU). EBCT scores were expressed in Agatston units, and the mean of 2 consecutive scans was used as the final EBCT score, unless only 1 scan was obtained. To minimize false-positive classifications of CAC prevalence due to tissue-associated artifact, we used a mean Agatston score Ͼ10 to define prevalent CAC, a data-derived threshold above which interscan concordance exceeded 95% (7 ).
MAGNETIC RESONANCE IMAGING
We performed abdominal MRI using a 1.5-T wholebody system (Intera; Philips Medical Systems) including 6 total slices of the infrarenal abdominal aorta using a free-breathing, electrocardiogram-gated, T2-weighted turbo spin-echo (black-blood) sequence. For each slide, adventitial and luminal borders were drawn using a freehand manual contour drawing tool. Areas of increased signal intensity, luminal protrusion, and focal wall thickening were identified as AAP and categorized dichotomously as present or absent (8 ) . For each slide, adventitial and luminal borders were drawn using a freehand manual contour drawing tool, and aortic wall area was calculated as the difference between the adventitial and luminal areas. We defined AWT as the ratio of the area of the aortic wall/mean aortic circumference. The mean value of the 6 slices was reported.
STATISTICAL ANALYSIS
Nominal data are reported as percentiles and continuous data as mean values with SDs or as median values with interquartile ranges (25th to 75th percentile) for non-normally distributed variables. Subjects were divided into sex-specific quartiles based on Lp-PLA 2 levels, as there are sex differences in Lp-PLA 2 distribution (5 ). Baseline demographic variables and cardiovascular risk factors were compared across quartiles of Lp-PLA 2 using the 2 trend test for nominal variables and the test for trend or the Kruskall-Wallis test across ordered groups for continuous variables. We determined associations between Lp-PLA 2 levels and the presence of detectable CAC or AAP using a series of univariable and multivariable logistic regression models, with adjustment for traditional risk factors (age, sex, race, LDL cholesterol, HDL-cholesterol, diabetes, smoking, hypertension), C-reactive protein (CRP) concentration, and statin use. Lp-PLA 2 mass and activity were analyzed in these models as continuous parameters, and odds ratios (ORs) were expressed per SD increment. We determined the association between Lp-PLA 2 levels and AWT (a continuous variable) using linear regression models adjusting for the same variables described above. All comparisons were 2-sided, and P Ͻ 0.05 was considered statistically significant.
Results
Age was 45 (9) years, and 46% were men. The mean (SD) and median (interquartile range) Lp-PLA 2 mass values were 191 (58) g/L and 187 (156 -220) g/L, respectively. Lp-PLA 2 activity values were 148 (39) and 145 (121-173) mol/min/L. Prevalent CAC and AAP were present in 21% and 40% of subjects, respectively. The mean (SD) and median aortic wall thickness was 1.70 (0.32) mm and 1.67 mm. Lp-PLA 2 mass was 205 (61) g/L in men and 180 (54) g/L in women, and Lp-PLA 2 activity was 163 (39) mol/min/L in men and 135 (34) mol/min/L in women. The association of baseline characteristics of the study population with sex-specific quartiles of Lp-PLA 2 mass is shown in Table 1 , and with Lp-PLA 2 activity, in Table 2 .
In univariable analyses, Lp-PLA 2 mass was associated with detectable CAC in both men (P ϭ 0.04) and women (P ϭ 0.02) ( Table 3 ; Fig. 1 ). After multivariable adjustment, Lp-PLA 2 mass remained modestly associated with detectable CAC in men (P ϭ 0.04) but not women (Table 3 ). In contrast, Lp-PLA 2 activity was not associated with detectable CAC in univariable or multivariable analyses in either sex (Table 3) .
In univariable analyses, higher Lp-PLA 2 mass and activity were associated with prevalent AAP in women (P ϭ 0.004 and P ϭ 0.01, respectively) but not men ( Fig. 2; Table 3 ). After multivariable adjustment, neither Lp-PLA 2 mass or activity was associated with AAP in men or women (Table 3) .
Finally, in univariable analysis, Lp-PLA 2 mass and activity were both associated with AWT in women (P Յ 0.02 for each) but not in men (P Ͼ 0.2). In linear regression analyses in which AWT was the dependent variable, adjusting for standard risk factors, CRP, and statin use, Lp-PLA 2 mass and activity were no longer associated with AWT in men or women (Table 3 ).
Discussion
Our study of a multiethnic population-based subject cohort shows that although Lp-PLA 2 activity and mass were associated modestly with selected atherosclerosis phenotypes in univariable analyses, most of these associations were attenuated or abolished after adjustment for standard risk factors. The only independent associ- ation observed was a modest one between Lp-PLA 2 mass and CAC that was evident only among men. Our study is the largest reported to date to evaluate the associations between LP-PLA 2 and CAC, and the first to examine the association of Lp-PLA 2 levels with AAP and AWT. Although Lp-PLA 2 mass and activity were higher in women with abdominal aortic atherosclerosis and a thicker abdominal aortic wall, the association was no longer significant after adjusting for other atherosclerosis risk factors. Few data are available regarding AWT as a marker of atherosclerosis, but it may provide information in the aorta similar to that of carotid intima-media thickness in the carotid arteries. Perrson et al. (9 ) recently reported a modest, yet statistically significant, independent association of Lp-PLA 2 mass and activity with carotid intima-media thickness measured by ultrasonography, but included only age and sex in the multivariable analysis.
Although Lp-PLA 2 mass and activity have been independently associated with cardiovascular clinical events in multiple (but not all (2 )) studies (1 ), the association with measures of atherosclerosis burden has been less consistent. Most studies have examined the association between Lp-PLA 2 levels and extent of coronary artery disease assessed by coronary angiography. Lp-PLA 2 mass and activity have been associated with the severity of angiographic coronary artery disease in univariable analyses in all published studies (10 -13 ) . The association of Lp-PLA 2 mass with angiographic coronary artery disease persisted after adjustment in 1 study (14 ) , but was no longer significant in another study (12 ) .
Three studies have examined the association of Lp-PLA 2 with CAC. In the Rotterdam populationbased study, Lp-PLA 2 activity was measured in 520 subjects Ͼ55 years of age; although Lp-PLA 2 activity was associated with CAC in univariable analysis, the association did not persist after adjustment for HDL and non-HDL cholesterol (15 ) . In the Coronary Artery Risk Development in Young Adults (CARDIA) nested case-control study, 266 subjects with CAC were compared with 266 controls (men comprised 71% of both The upper, middle, and lower lines of the shaded box correspond to the 75th percentile, median, and 25th percentile values. The upper line at the end of the whisker coming out of the box on the upper side is the minimum value of either a) the maximum value in the dataset or b) the largest value in the dataset that is less than the upper quartile value plus 1.5 times the interquartile range (IQR). The lower line at the end of the whisker coming out of the box on the lower side is the maximum value of either a) the minimum value in the dataset or b) the smallest value in the dataset that is more than the lower quartile value minus 1.5 times the IQR. groups) (3 ). Both Lp-PLA 2 mass and activity were associated with CAC in univariable analysis; after adjusting for age, educational attainment, smoking, alcohol consumption, body mass index, waist circumference, diabetes, hypertension, LDL and HDL cholesterol, triglycerides, and CRP, Lp-PLA 2 mass maintained its association with detectable CAC (OR 1.28 per SD, 95% CI 1.03-1.60), whereas Lp-PLA 2 activity did not (OR 1.09 per SD, 95% CI 0.84 -1.42) (3 ) . Finally, in a small study of 100 American (research volunteers) and 100 Japanese (population-based) men, Lp-PLA 2 activity was not associated with CAC in American men and was inversely associated with CAC in Japanese men, although no multivariable adjustment was performed (16 ) .
The findings of our study are very similar to the above studies, with the further finding that Lp-PLA 2 mass was independently associated with CAC in men but not women. This may be due to the higher CAC prevalence and significantly higher Lp-PLA 2 levels seen in men compared with women (5 ). The lack of independent association of Lp-PLA 2 activity with CAC in both CARDIA (3 ) and our study could be in part due to the stronger association of Lp-PLA 2 activity (Spearman's correlation coefficient ϭ 0.42) compared to Lp-PLA 2 mass (Spearman's correlation coefficient ϭ 0.33) with LDL cholesterol. These findings do not support an incremental role of LP-PLA 2 activity over mass for the identification of subclinical atherosclerosis.
Although Lp-PLA 2 levels do not appear to be strongly associated with atherosclerotic burden, higher levels have been associated with an increased incidence of cardiovascular events in multiple studies (17 ) . This has also been described for other biomarkers, such as CRP (18 ) , and suggests that Lp-PLA 2 may be a better marker of atherosclerosis activity and vulnerability rather than atherosclerosis burden. In the Dallas Heart Study, higher CRP was associated with more extensive coronary and aortic atherosclerosis in men; on multi- The upper, middle, and lower lines of the shaded box correspond to the 75th percentile, median, and 25th percentile values, respectively. The upper line at the end of the whisker coming out of the box on the upper side is the minimum value of either a) the maximum value in the dataset or b) the largest value in the dataset that is less than the upper quartile value plus 1.5 times the interquartile range (IQR). The lower line at the end of the whisker coming out of the box on the lower side is the maximum value of either a) the minimum value in the dataset or b) the smallest value in the dataset that is more than the lower quartile value minus 1.5 times the IQR. variable analysis, however, the association was no longer significant (18 ) .
Lp-PLA 2 activity measurement was performed on frozen rather than fresh specimens, but Lp-PLA 2 has been shown to be stable in repeated freeze-thaw cycles (12 ) . Because limited amount of available plasma, repeat measurements could not be performed for Lp-PLA 2 mass, and therefore we could not measure the duplicate CV for samples, although the duplicate CV for controls was low. The finding of an association only between Lp-PLA 2 mass and coronary atherosclerosis and only in the subgroup of men could be the result of chance. All observations were cross-sectional, since follow-up for clinical events is not yet available on the Dallas Heart Study cohort.
In conclusion, Lp-PLA 2 mass and activity were not found to be independently associated with abdominal aortic atherosclerosis or with abdominal aortic wall thickness. Lp-PLA 2 activity was not found to be independently associated with detectable CAC, whereas Lp-PLA 2 mass was independently associated with detectable CAC in men but not women. Previously reported associations between Lp-PLA 2 and clinical cardiovascular events (17 ) may be related to atherosclerotic plaque instability rather than atherosclerotic burden.
